Organofluorine compounds possess unique physical properties that are exploited in a wide range of applications such as dyes, polymers, agrochemicals, and pharmaceuticals. 1 In medicinal chemistry, for example, valuable physiological properties are often conferred on "drug-like" molecules via the incorporation of CF 3 groups that enhance binding selectivity, elevate lipophilicity, and/ or improve metabolic stability.
whose mechanistic foundation relies on the propensity of electrophilic radicals (derived from the reduction of an alkyl halide by a photoredox catalyst (e.g., 1)) to combine with facially biased enamine intermediates (derived from aldehydes and chiral amine catalyst 2). Inspired by this strategy, we hypothesized that the enantioselective R-trifluoromethylation of aldehydes should also be possible by the marriage of two similar activation pathways. As detailed in Scheme 1, we anticipated that Ir(ppy) 2 (dtb-bpy) + 1, 11 previously employed as a photosynthesis mimic, should readily accept a photon from a variety of light sources within the visible spectrum (such as a household fluorescent bulb) to populate the *Ir(ppy) 2 (dtb-bpy) + 7 excited state. Given its known tendency toward reductive quenching, we presumed that *Ir(ppy) 2 (dtb-bpy) + 7 would readily accept a single electron from a sacrificial quantity of enamine (0.5 mol %) to form a strong reductant Ir(ppy) 2 (dtbbpy) 8 (-1.51 V vs SCE in CH 3 CN). 12, 13 At this stage we anticipated that this electron-rich iridium system 8 would participate in single electron transfer (SET) with trifluoromethyl iodide (-1.22 V vs SCE in DMF) 14 to render the electrophilic radical 3, while regenerating the photoredox catalyst 1. In concert with this radical formation pathway, we expected that an organocatalytic cycle would initiate by condensation of the imidazolidinone catalyst 2 with an aldehyde substrate to form the enamine 4. The merger of the two activation pathways would then occur in the key alkylation step via rapid addition of the trifluoromethyl radical 3 to the π-rich olefin 4 to form the R-amino radical 5. Given that radical 5 should have a low barrier to oxidation, 15 a second electron transfer event with the *Ir(ppy) 2 (dtb-bpy) + 7 excited state would close the photoredox cycle and deliver the iminium ion 6. Rapid hydrolysis of iminium 6 would then reconstitute the organocatalyst 2 while rendering the optically enriched R-CF 3 aldehyde. As a critical design element, we anticipated high levels of enantiocontrol resulting from positioning of the 4π-electron system of activated enamine DFT-4 away from the bulky tert-butyl group, while also adopting an (E)-configuration to minimize nonbonding interactions. 16 In this arrangement, the methyl group on the imidazolidinone scaffold effectively shields the Re face, leaving the Si face exposed toward electrophilic radical addition.
Our photoredox fluoroalkylation was first evaluated using octanal and trifluoromethyl iodide along with imidazolidinone catalysts 2 or 10, photoredox catalysts 1 or 9, and a 26 W fluorescent household lamp (Table 1) . Initial experiments revealed that the proposed alkylation reaction was indeed possible using a combination of Ru(bpy) 3 2+ (9) and the amine catalyst 10 (entry 1, 51% yield), albeit to render a racemic product. Importantly, exclusion of light from this protocol resulted in almost complete loss of catalyst efficiency (<5% yield), in accord with the photoredox mechanism outlined in Scheme 1. While the use of Ir(ppy) 2 (dtb-bpy) + 1 allowed a significant increase in reaction yield (entry 3, 85%), it was not until subambient temperatures were employed that enantioinduction was observed (entry 4, -20°C, 52% ee). Moreover, implementation of the trans-tert-butyl-methyl imidazolidinone catalyst 2 (along with photocatalyst 1) provided almost perfect enantiocontrol in the trifluoromethylation step without detectable post-reaction racemization (entry 6, 79% yield, 99% ee). 17 The superior levels of induction and efficiency exhibited by the combination of organocatalyst 2 with photoredox catalyst 1 in DMF at -20°C prompted us to select these conditions for further exploration. 18, 19 We next performed a series of experiments to determine the scope of the aldehydic component in this asymmetric trifluoromethylation protocol. As revealed in Table 2 , these mild redox conditions are compatible with a wide range of functional groups including ethers, esters, amines, carbamates, and aromatic rings (entries 2-4, 6, 8, 9, 61-86% yield, 93-98% ee). Moreover, significant variation in the steric demand of the aldehyde substituent can be accommodated without loss in enantiocontrol (entries 5-7, 10, and 11, g90% ee).
Notably, this protocol enables the formation of a benzylic-CF 3 R-formyl stereocenter without significant erosion in enantiopurity (entry 8, 61% yield, 93% ee). 21 As highlighted in entries 10 and 11, exposure of enantiopure (R)-3-phenyl-butyraldehyde to catalyst (2S,5R)-2 results in the diastereoselective production of the anti R, -disubstituted isomer, while the use of (S)-3-phenyl-butyraldehyde with the same amine catalyst affords the corresponding syn adduct with high fidelity. These transformations clearly demonstrate the synthetic advantages of catalyst-enforced induction versus substrate-directed stereocontrol.
We have found that a broad range of perfluoroalkyl iodides and bromides also participate in this enantioselective alkylation reaction (Table 3) . For example, n-perfluoroalkyl substrates of varying chain length undergo reductive radical formation and enamine addition without loss in enantiocontrol or reaction efficiency (entries 1-3 and 5-8, 67-89% yield, 96-99% ee). We have also found that the aldehyde R-functionalization step can be performed with sterically demanding coupling partners such as perfluoro-isopropyl iodides (entry 4, 72% yield, 98% ee). Moreover, benzylic, R-ester, and R-ether difluoromethylene carbons are readily incorporated as part of this new enantioselective catalytic R-carbonyl alkylation.
We fully expect that the R-trifluoromethyl aldehyde products generated in this study will be of value for the production of a variety of organofluorine synthons. As shown in Scheme 2, reduction or oxidation of the formyl group is possible to generate -hydroxy and R-trifluoromethyl acids (the latter we expect will be a key building block for the formation of heterocycles that incorporate CF 3 at the benzylic position). Moreover, these aldehyde products can be employed in a reductive amination sequence without significant loss in enantioselectivity to produce -trifluoromethyl amines. Last, and perhaps most important, aldehyde oxidation followed by a Curtius rearrangement allows enantioselective formation of R-trifluoromethyl amine containing stereocenters, a commonly employed amide isostere in medicinal chemistry.
2 In this case, careful selection of base and reaction temperature is essential to maintain the enantiopurity obtained in the initial alkylation step.
In summary, the first enantioselective, organocatalytic R-trifluoromethylation and R-perfluoroalkylation of aldehydes have been accomplished using a readily available iridium photocatalyst and a commercial imidazolidinone catalyst. Full details of this survey will be forthcoming. The addition of 2,6-lutidine is necessary to remove hydroiodic acid that is formed during the reaction. Rapid racemization of the R-CF 3 formyl adduct was observed at room temperature but not at -20°C. (19) Lower reaction efficiency appears to lead to lower enantiopurity as the product is exposed to unconsumed base (i.e., Table 1 , entry 5, catalyst 9). (20) A hitherto unreported amine catalyst 11 was employed in entry 7 (Table 2) at -78°C before addition of CF 3 I (∼8 equiv), followed by aldehyde (0.76 mmol, 1.0 equiv) and 2,6-lutidine (1.1 equiv). The reaction vessel was placed near a 26 W compact fluorescent light bulb in a -20°C bath for 7.5-8 h. Upon reaction completion, the R-trifluoromethyl aldehydes were typically reduced in situ with NaBH 4 (10 equiv) in CH 2 Cl 2 and MeOH to afford -trifluoromethyl alcohols in high yield and enantioselectivity. 
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